Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 28, 2005; 11(36): 5696-5700
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5696
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5696
Figure 2 Relation between survival rates of 36 patients and staging of esophageal cancer.
No significant difference was seen between survival curves of the p53-negative and p53-positive patients and esophageal cancer staging.
- Citation: Sunada F, Itabashi M, Ohkura H, Okumura T. p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy. World J Gastroenterol 2005; 11(36): 5696-5700
- URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5696.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i36.5696